Beximco has already signed a deal with Serum to bring 30 million doses of the vaccine developed by Britain’s AstraZeneca and the University of Oxford. Rabbur Reza, chief operating officer of Beximco Pharmaceuticals, said on Friday that discussions were ongoing for the import of the 1 million doses besides the 30 million. “We are thinking about prioritising those in the frontline in the business sector, especially in the pharmaceutical sector, for the distribution of these (1 million) doses. Bangladesh will get the 30 million doses from Serum at $5 per shot. For the additional 1 million doses, Beximco will have to pay $8 per shot.

Source: bd News24 November 27, 2020 15:45 UTC